Columbia Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$231K Hold
2,900
0.1% 132
2023
Q3
$206K Hold
2,900
0.12% 128
2023
Q2
$223K Hold
2,900
0.13% 122
2023
Q1
$218K Sell
2,900
-200
-6% -$14.9K 0.13% 125
2022
Q4
$244K Hold
3,100
0.14% 126
2022
Q3
$218K Hold
3,100
0.12% 124
2022
Q2
$248K Hold
3,100
0.13% 128
2022
Q1
$251K Sell
3,100
-100
-3% -$7.92K 0.12% 134
2021
Q4
$242K Hold
3,200
0.13% 123
2021
Q3
$242K Buy
3,200
+200
+7% +$15.9K 0.13% 124
2021
Q2
$244K Sell
3,000
-200
-6% -$16.4K 0.14% 127
2021
Q1
$252K Hold
3,200
0.16% 123
2020
Q4
$273K Buy
+3,200
New +$265K 0.19% 116
2020
Q2
$234K Hold
3,200
0.21% 111
2020
Q1
$212K Hold
3,200
0.23% 108
2019
Q4
$220K Buy
+3,200
New +$218K 0.2% 123

Other funds holding CL

Columbia Trust's CL Position: Q4 2023 in Review

Columbia Trust held its Colgate-Palmolive (CL) position steady in Q4 2023 at 2,900 shares worth $231K. The position accounts for 0.1% of the portfolio, ranked #132.

Columbia Trust first reported a position in CL in Q4 2019 and has held it in 16 quarters since. The position peaked at $273K in Q4 2020. 1,740 funds tracked by Wall St. Rank hold CL as of Q4 2023.

  • Columbia Trust held 2,900 shares of Colgate-Palmolive worth $231K as of Q4 2023.
  • Columbia Trust left its Colgate-Palmolive share count unchanged in Q4 2023.
  • Colgate-Palmolive made up 0.1% of Columbia Trust's portfolio in Q4 2023, its #132 holding.
  • Columbia Trust first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 16 quarters since.
  • Columbia Trust's Colgate-Palmolive position peaked at $273K in Q4 2020.
  • 1,740 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2023.

Based on Columbia Trust's 13F filing for Q4 2023, filed 17 Jan 2024.